
You are about to leave www.astellas.com and enter a third-party website. Astellas is not responsible for the content or services on the third-party website.
Would you like to continue?
Astellas is committed to providing timely and accurate information about our business, science and products. This section offers local resources for investors, journalists and media professionals. Global news and resources can be viewed here. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-Total Funds To Be Awarded Increased to $200,000; All Encouraged to Apply - - Cancer Advocates and Celebrities Bill and Giuliana Rancic Participate in Fourth Annual Challenge - NORTHBROOK, Ill.,...
NORTHBROOK, Ill., May 9, 2019 /PRNewswire/ -- Astellas is proud to announce that Chelsea Glinski, executive director, Reimbursement Strategy will be recognized by the Healthcare Businesswomen's...
- Data Presented at the American Urological Association 2019 Annual Meeting - CHICAGO, May 5, 2019 /PRNewswire/ -- Astellas Pharma Inc. today announced results from the Phase 4, 12-week PLUS...
April 25, 2019 -- Astellas and the U.S. Department of Justice (DOJ) have reached an agreement to resolve all claims raised by the government in its investigation regarding Astellas’ past...
NORTHBROOK, Ill., April 3, 2019 /PRNewswire/ -- Astellas is pleased to announce two recent senior-level promotions and one new hire within its Medical and Development (M&D) organization. Steven...